Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis.
Saved in:
| Title: | Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis. |
|---|---|
| Authors: | Tanni KA; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL 36849, USA. Electronic address: kzt0031@auburn.edu., Truong CB; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL 36849, USA. Electronic address: bct0022@auburn.edu., Johnson BS; Spencer Cancer Center, East Alabama Medical Center, Opelika, AL 36801, USA. Electronic address: brandon.johnson@eamc.org., Qian J; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL 36849, USA. Electronic address: jzq0004@auburn.edu. |
| Source: | Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2021 Jul; Vol. 163, pp. 103375. Date of Electronic Publication: 2021 Jun 02. |
| Publication Type: | Journal Article; Meta-Analysis; Systematic Review |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-0461 |
|---|---|
| DOI: | 10.1016/j.critrevonc.2021.103375 |
